These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 8607139

  • 1. Effects of paraquat on the substantia nigra of the wistar rats: neurochemical, histological, and behavioral studies.
    Liou HH, Chen RC, Tsai YF, Chen WP, Chang YC, Tsai MC.
    Toxicol Appl Pharmacol; 1996 Mar; 137(1):34-41. PubMed ID: 8607139
    [Abstract] [Full Text] [Related]

  • 2. Attenuation of paraquat-induced dopaminergic toxicity on the substantia nigra by (-)-deprenyl in vivo.
    Liou HH, Chen RC, Chen TH, Tsai YF, Tsai MC.
    Toxicol Appl Pharmacol; 2001 Apr 01; 172(1):37-43. PubMed ID: 11264021
    [Abstract] [Full Text] [Related]

  • 3. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM, Banerjee R, Senthilkumar KS, Saravanan KS, Raju BC, Rao JM, Mohanakumar KP.
    Pharmacol Biochem Behav; 2006 Jun 01; 84(2):321-9. PubMed ID: 16820197
    [Abstract] [Full Text] [Related]

  • 4. Dietary administration of paraquat for 13 weeks does not result in a loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice.
    Minnema DJ, Travis KZ, Breckenridge CB, Sturgess NC, Butt M, Wolf JC, Zadory D, Beck MJ, Mathews JM, Tisdel MO, Cook AR, Botham PA, Smith LL.
    Regul Toxicol Pharmacol; 2014 Mar 01; 68(2):250-8. PubMed ID: 24389362
    [Abstract] [Full Text] [Related]

  • 5. Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra.
    Sengstock GJ, Olanow CW, Dunn AJ, Barone S, Arendash GW.
    Exp Neurol; 1994 Nov 01; 130(1):82-94. PubMed ID: 7529713
    [Abstract] [Full Text] [Related]

  • 6. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
    Rojo AI, Cavada C, de Sagarra MR, Cuadrado A.
    Exp Neurol; 2007 Nov 01; 208(1):120-6. PubMed ID: 17880941
    [Abstract] [Full Text] [Related]

  • 7. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
    Ahmad M, Saleem S, Ahmad AS, Yousuf S, Ansari MA, Khan MB, Ishrat T, Chaturvedi RK, Agrawal AK, Islam F.
    J Neurochem; 2005 Apr 01; 93(1):94-104. PubMed ID: 15773909
    [Abstract] [Full Text] [Related]

  • 8. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C, Nikkhah G, Cunningham MG, Björklund A.
    Exp Neurol; 1999 Sep 01; 159(1):177-90. PubMed ID: 10486186
    [Abstract] [Full Text] [Related]

  • 9. Acute intranigral homocysteine administration produces stereotypic behavioral changes and striatal dopamine depletion in Sprague-Dawley rats.
    Chandra G, Gangopadhyay PK, Senthil Kumar KS, Mohanakumar KP.
    Brain Res; 2006 Feb 23; 1075(1):81-92. PubMed ID: 16487496
    [Abstract] [Full Text] [Related]

  • 10. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery.
    Lapchak PA, Miller PJ, Collins F, Jiao S.
    Neuroscience; 1997 May 23; 78(1):61-72. PubMed ID: 9135089
    [Abstract] [Full Text] [Related]

  • 11. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N, Vidal L, Alvarez P, Blanco L, Torres A, Rodríguez A, Macías R.
    Rev Neurol; 1998 Jun 23; 26(154):915-8. PubMed ID: 9658459
    [Abstract] [Full Text] [Related]

  • 12. Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats.
    Cicchetti F, Lapointe N, Roberge-Tremblay A, Saint-Pierre M, Jimenez L, Ficke BW, Gross RE.
    Neurobiol Dis; 2005 Nov 23; 20(2):360-71. PubMed ID: 16242641
    [Abstract] [Full Text] [Related]

  • 13. Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration.
    Wenning GK, Granata R, Laboyrie PM, Quinn NP, Jenner P, Marsden CD.
    Mov Disord; 1996 Sep 23; 11(5):522-32. PubMed ID: 8866493
    [Abstract] [Full Text] [Related]

  • 14. Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease.
    Ossowska K, Smiałowska M, Kuter K, Wierońska J, Zieba B, Wardas J, Nowak P, Dabrowska J, Bortel A, Biedka I, Schulze G, Rommelspacher H.
    Neuroscience; 2006 Sep 15; 141(4):2155-65. PubMed ID: 16797138
    [Abstract] [Full Text] [Related]

  • 15. Neuroprotective effects of Polygonum multiflorum on nigrostriatal dopaminergic degeneration induced by paraquat and maneb in mice.
    Li X, Matsumoto K, Murakami Y, Tezuka Y, Wu Y, Kadota S.
    Pharmacol Biochem Behav; 2005 Oct 15; 82(2):345-52. PubMed ID: 16214209
    [Abstract] [Full Text] [Related]

  • 16. Behavioral and anatomical effects of quinolinic acid in the striatum of the hemiparkinsonian rat.
    Olds ME, Jacques DB, Kopyov O.
    Synapse; 2005 Jan 15; 55(1):26-36. PubMed ID: 15499610
    [Abstract] [Full Text] [Related]

  • 17. No changes in behaviour, nigro-striatal system neurochemistry or neuronal cell death following toxic multiple oral paraquat administration to rats.
    Widdowson PS, Farnworth MJ, Upton R, Simpson MG.
    Hum Exp Toxicol; 1996 Jul 15; 15(7):583-91. PubMed ID: 8818712
    [Abstract] [Full Text] [Related]

  • 18. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
    Lorenc-Koci E, Antkiewicz-Michaluk L, Kamińska A, Lenda T, Zieba B, Wierońska J, Smiałowska M, Schulze G, Rommelspacher H.
    Neuroscience; 2008 Oct 28; 156(4):973-86. PubMed ID: 18809471
    [Abstract] [Full Text] [Related]

  • 19. Dopamine cell morphology and glial cell hypertrophy and process branching in the nigrostriatal system after striatal 6-OHDA analyzed by specific sterological tools.
    Gomide V, Bibancos T, Chadi G.
    Int J Neurosci; 2005 Apr 28; 115(4):557-82. PubMed ID: 15804725
    [Abstract] [Full Text] [Related]

  • 20. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
    Moroz IA, Peciña S, Schallert T, Stewart J.
    Exp Neurol; 2004 Sep 28; 189(1):78-93. PubMed ID: 15296838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.